Global Ganja Report

On July 3, medical marijuana users can head out to Quixote’s True Blue bar in Denver, Colorodo, to experience the HomeGrown Freedom Festival, a gathering and concert exclusively for MMJ patients. This gathering is designed to connect patients with the local dispensaries and caregivers that best fit the individual’s needs.

California cannabis activist Ed Rosenthal has filed the first formal complaint in a notorious SWAT team raid of a home in Columbia, Mo., that has garnered more than a million hits on YouTube.

A new drug made from cannabis has been licensed in the UK. Sativex, a tincture of extracts from the plant, is sprayed under the tongue up to 12 times a day, as a treatment for the stiffness and spasticity associated with multiple sclerosis. The Home Office has rated it as having zero abuse potential. Britain is the first country to give the drug full regulatory approval, although Canada gave Sativex a limited license to treat neuropathic pain in 2005. It is made from plants grown at a secret location in southern England by GW Pharmaceuticals, whose shares have risen 60% in the last six months in anticipation of the new product.

Months after Iowa's pharmacy board recommended the state approve a medical marijuana law, progress is stymied as a legislative leader and a board official each say the other needs to act.

US biotech firm Cannabis Science, Inc.  reports that Montana Gov. Brian Schweitzer visited its latest acquisition, Montana Pain Management in Missoula, June 17. Governor Schweitzer reportedly praised the project; "You are doing it right."

Territorial Sen. Rory Respicio June 16 revised and reintroduced his bill that would allow for the medicinal use of marijuana on Guam. Among changes to the Compassionate Health Care Act, now Bill 423, language was added to state that doctors cannot write prescriptions for cannabis, but can recommend its use and certify that recommendation.

Oregon on June 16 became the latest state and the first in many years to officially reclassify cannabis from its status as a dangerous drug with no medical value. The Oregon Board of Pharmacy (BoP) voted 4-1 to move cannabis from Schedule I to Schedule II. The Oregon BoP decision comes after many months of deliberation and input from the public.

The California State Assembly Committee on Health voted 10-3 on June 15 to pass a resolution urging the federal government to end medical marijuana raids and to "create a comprehensive federal medical marijuana policy that ensures safe and legal access to any patient that would benefit from it."